Adjustable-Size Interatrial Shunt Demonstrates Early Feasibility in Heart Failure. First-in-human trial. Source : Medical News,November 25, 2025
Adjustable-Size Interatrial Shunt Demonstrates Early Feasibility in Heart Failure. First-in-human trial.
Source : Medical News,November 25, 2025
Keynotes :
1. First-in-human trial tested a new adjustable interatrial shunt for advanced heart failure.
2. Device can change size over time and continuously measures atrial pressures.
3. Implanted successfully in 10 patients with no major complications.
4. At 90 days: shunt size could be readjusted in all patients, and pressures were sent remotely.
5. Early signs: patients felt better and natriuretic peptides dropped.
6. A new study (ATLANTIS) is enrolling more patients.
7. Interatrial shunts aim to reduce high left atrial pressure, a key cause of HF symptoms.
8. The first similar device (V-Wave) goes to FDA panel review on Dec 3.
